GI & Endoscopy

Here were the five most read gastroenterology/endoscopy stories on Becker's ASC Review for the week of Nov. 28 to Dec. 2, 2016.

Nancy Kang, MD, is a gastroenterologist with Connecticut (Hartford) Gastroenterology Associates.

The American Gastroenterological Association's patient education portal Patient INFO Center can be loaded onto gMed, a gastroenterology EHR system.

Here are three updates on gastroenterology and endoscopy companies.

Laval, Canada-based Valeant Pharmaceuticals will hold onto its gastrointestinal division, Salix, after talks fell apart with Japan's Takeda Pharmaceuticals, Bloomberg reports.

Scott D. Becker, MD, is a gastroenterologist and the director of clinical research at Austin (Texas) Gastroenterology.

Here are three gastroenterologists in the news this past week.

Despite falling revenues, Madison, N.J.-based Allergan's gastroenterology franchise grew by 8.2 percent in the third quarter, Market Realist reports.

Cambridge, Mass.-based Idera Pharmaceuticals and Bermuda-based Vivelix Pharmaceuticals entered into an exclusive license and collaboration agreement giving Vivelix the rights to develop and market IMO-9200, an antagonist of TLR 7,8 and 9, for non-malignant gastrointestinal disorders.

Michael Gilbert Goggins, MD, is a gastroenterologist and a professor of pathology, medicine and oncology at Baltimore's John Hopkins Medicine.